dies have proven a significant correlation between TAMs and "tumor vessel density" and their negative influence on the survival of patients. Tumour infiltrating DCs are predominantly immature and their stimulation signals for cytotoxic T lymphocytes are insufficient. The presence of DCs cannot be considered the manifestation of the effective anti-tumour response. DCs can directly produce proangiogenic factors and regulate other components of innate and acquired immune response, which participate in angiogenesis. TAMs and DCs also induce chemotaxis of polymorphonuclear leukocytes (PMNL) through CXCL1, CXCL2, CXCL3, CXCL5, CXCL7, CXCL8 chemokines (26) . Due to this stimulation, the increase of adhesive molecules and their ligands occurs on the vascular endothelium and on the PMNL membrane (14) . PMNL release large amounts of enzymes, which split the intercellular mass (15) . It depends on many factors of tumour microenvironment, whether the anti-tumour immune response or the angiogenic effect prevail.
Tumour growth and its progression is accompanied with the increase in a number of angiogenic factors. There are a number of experimental and clinical observations, which prove the complexity of regulations in angiogenesis. One example is chemokines of the CXC superfamily. These chemokines act both in proangiogenic and angiostatic ways. The difference in effect is given by the sequence of three amino-acids -Glu-Leu-Arg (ELR) at the N terminus (9) . ELR + CXC chemokines (i.e. CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, CXCL8) show proangiogenic features, while ELR -CXC chemokines (i.e. CXCL4, CXCL9, CXCL10, CXCL11) blunt the proliferation of capillaries (17) . In patients with metastatic RCC higher serum levels of CXCL1, CXCL3, CXCL5, CXCL8 were found in comparison with healthy donors (9) . ELR + CXC chemokines significantly increase angiogenesis in various types of tumours (5, 25) . Growth-related oncogenes-α, β, γ (GRO-α, β, γ) (CXCL1, CXCL2, CXCL3 chemokines) were tested on melanoma cells and they potentiated the proliferation of these cells (8) . In the case of patients with a non-small cell lung carcinoma, vascularization and the development of metastases were potentiated by epithelialneurophil-activating peptide 78 (ENA-78) (CXCL5 chemokine) and IL-8 (CXCL8 chemokine) (11, 14) . On the basis of these findings, we may assume that ELR + CXC chemokines are an important factor of malignancy even in other tumours, i.e. renal carcinoma.
The other angiogenic factor, which was evaluated, was angiogenin. Angiogenin is a protein with a molecular weight of 170 kDa, it differs from the other members of the superfamily of ribonucleasis by the absence of the 4th disulphide bond between two cysteine residues. Both described E and K variants bind to receptors found on endothelial cells and show a proangiogenic effect (19) . Angiogenin is detected in a number of organs in the course of embryogenesis (18) . Fett (1985) was the first scientist, who proved its influence on the vessel growth of the chicken embryos (4) . In healthy individuals the angiogenin concentration in plasma, ranges within 250-360 μg/L (6). Most of the studies which deal with neo-angiogenesis in RCC proved no correlation amongst the disease stage, cellular grading, angiogenin, VEGF and bFGF (basic Fibroblast Growth Factor) levels. No correlation between angiogenin level and survival rate was confirmed either. Significant differences in the serum angiogenin level were described only among healthy blood donors and in patients with metastasing RCC. The angiogenic factors were determined by means of the ELISA method (22) .
Material and Methods
Renal cell carcinoma was diagnosed in 32 patients during the period from October 2005 till September 2006. In all the patients the primary renal tumour was removed. Eight resections and 24 nephrectomies were carried out. The diagnosis of clear cell renal carcinoma was confirmed histologically, and in all the cases the cellular grading was determined according to Fuhrman. Patient sera was obtained by repeated peripheral venous blood collections, which were carried out on the day of surgery, day 7 and 8 weeks post-surgery. None of samples was influenced by an adjuvant therapy. One hour after blood collection each blood sample was centrifuged at 3000 rpm for 10 minutes. Sera was subsequently divided into two parts and stored at a temperature of -20°C till the time of processing. Control sera was obtained from 14 healthy blood donors of similar age. In order to determine the level of angiogenic factors, the protein array method of the RayBiotech Company (USA), RayBio Human Angiogenesis Antibody Array I, was used. This method is based on a membrane covered with spots, where specific antibodies to individual factors under examination are bound. After the application of the sample, the analyzed proteins bind to the appropriate antibodies. In the next step, the mixture of antibodies to measured proteins conjugated with enzyme is applied. The immunocomplexes which came into existence and are fixed in the area of appropriate spots are visualized by a suitable colour reaction. The result is a membrane with visible spots of different intensities. The concentration of an appropriate factor then complies with the intensity of the colouring of a particular spot. The membrane also contains, besides the measured parameters, negative and positive controls. The evaluation was carried out by means of ARES ARay Evaluation System software (Baria, Czech Republic). The resulting concentration of individual proteins was expressed as the relative value of spot colouring in comparison to controls. The statistical evaluation of measured values was carried out by means of the Sigmastat programme.
Results
The clinical specifications e.g. sex (11 women and 21 men), age (an average age of 65.9 years), disease stage based on TNM classification (10 th revision, 2002), grade, number and localization of metastasis are summarized in Table 1 . The results of measurements are shown in Table 2 and the Graphs (Fig. 1a-c, Fig 2a-c, Fig 3a-c) .
We discovered a significant increase both in pre-operative (on the day of surgery) and post-operative (on the day 7 and 8 weeks post-surgery) angiogenin, panGRO and T1a  N0  M0  I  none  12  m  50  II  T2  N0  M0  II  none  13  m  66  II  T2  N0  M0  II  none  14  m  54  I  T1a  N0  M0  III  none  15  m  78  I  T1a  N0  M0  II  none  16  f  83  III  T3a  N0  M0  I-II  adrenal  17  m  66  III  T3b  N0  M0  II  renal vein  18  f  73  III  T3b  NX  M0  III  renal vein  19  m  64  III  T3b  N0  M0  II  renal vein  20  m  57  III  T3a  N0  M0  II-III  bilteral RCC  21  f  66  III  T3a  N0  M0  II  adrenal  22  f  77  III  T3a  N0  M0  II-III  adrenal  23  m  75  III  T3a  N0  M0  I-II  adrenal  24  m  77  IV  T3a  NX  M1  III  liver (1)  25  m  74  IV  T4  N0  M1  III- 
Tab. 2:
Comparison of relative levels of chemokines in samples before surgery, 7 days and 8 weeks after surgery.
ENA-78 levels in all stages of the disease (I+II, III, IV) in comparison with the group of healthy blood donors (p-values in the Table 2 ). We found no correlation between the levels of angiogenin and stages I+II, III and IV RCC. Patients with advanced carcinoma (stage III) had pre-operatively higher serum levels of ENA-78 than patients with stages I+II (p = 0,009) and IV (p< 0.001). Eight weeks after surgery the patients with stages I+II had significantly higher levels of panGRO than patients with stage IV. centrations in the samples taken from patients divided into groups based on their disease stage and from healthy blood donors. This method shows good specificity and sensitivity (7, 21) . Its big advantage is the possibility to determine a number of parameters in one analytical cycle, but its disadvantage is the detection only in one concentration of the sample under examination. If the analyzed samples contain very low or very high concentrations of measured protein, it is difficult or even impossible to identify them.
In patients with carcinoma (e.g. ovarian, endometrial and renal cancers) a significantly higher level of most of the angiogenic factors in the serum is described.
Similar findings were discovered in our group of patients by means of a multiplex protein array analysis. A significant pre-operative increase in angiogenin of patients in comparison with healthy donors was noted in all stage of RCC. This increase in angiogenin continued two months after the tumour removal, even in patients with stages I and II RCC, without proven metastases. These findings can be explained by the process of postoperative wound healing. By comparing the angiogenin levels before the surgery and one week after the surgery a non-significant difference was seen.
The other following factors were pan GRO (CXCL1-3) and ENA-78 (CXCL-5) chemokines. Similarly, as in the case of angiogenin, we discovered a significant pre-operative increase in panGRO and ENA-78 chemokines both in advanced and metastasing RCC (stages III and IV) and in patients with localized tumours on the kidney (stages I and II). The subsequent slight increase in these chemokines in the samples taken on day 7 after surgery was probably associated with the healing of the post-operative wound. This assumption complies with the studies of Wu (2003) and Riese (2000) (12, 24) .
The long-term increase in angiogenic factors is described also in patients with a burn-healing of the post-operative wound, in patients with the chronic infectious and chronic inflammatory diseases (e.g. diabetes mellitus, rheumatoid arthritis, bronchial asthma, etc. (1, 16, 23) . In our patients, the healing of post-operative wounds was without complications, and none of our patiens suffered from chronic inflammatory disease at the time of surgery.
Laparotomy and following abdominal surgery are accompanied with an increase in IL-1, IL-6, IL-8, G-CFS and MPC-1 in the peritoneal cavity, with or without an insignificant systemic response. The inflammatory post-operative reaction is compartmentalized with the highest cytokine and chemokine concentration at the site of tissue damage (16) . These observations explain our findings, why angiogenin, GRO and ENA-78 levels were not significantly increased in the post-operative period and during the healing of post-operative wounds in comparison with preoperative state.
Conclusions
The study summarizes our experience with the multiparametric analysis of angiogenesis in RCC. The selected 
Discussion
The protein array method, which we used for the analysis, did not allow us to quantify the levels of monitored factors. This method only expresses the ratio of serum conmethod allows monitoring the dynamic of changes of serum levels of angiogenin, panGRO and ENA-78 with sufficient sensitivity. However, its prognostic significance has not yet been confirmed. It seems that the serum levels of chemokines in patients with RCC can reflect the advanced stage of disease. Pluripotent ELR+ CXC chemokines play a significant role during the regulation of inflammatory reactions of various etiologies. On top of that, chemokines are quickly degradated already at the site of inflammation, and their serum levels do not reflect the extent of the inflammatory reaction. Only detailed knowledge of the microenvironment, which determines the character of the resulting immune response, can help us interfere in the cellular interactions of the immune system effectively.
